Allergists Dr Andrew Clark and Dr Shuaib Nasser offer tips on who needs one and advice to give patients 1. Any patient who has experienced symptoms of airway narrowing or cardiovascular compromise ...
NHSBSA prescription data drives clinical research to enhance anaphylaxis management and patient safety14 January 2026Two new research papers show how NHS Business Services Authority (NHSBSA) ...
Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
A third of people in England who have experienced a severe allergic reaction to food are not carrying live-saving adrenaline pens, analysis shows. Prescriptions for adrenaline auto injectors (AAIs) – ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched new guidance to highlight the latest safety advice on the steps to take during anaphylaxis. This new guidance includes an ...
If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) to launch its adrenaline autoinjector (AAI), Jext®, in China via a partnership with leading supplier of adrenaline, Grandpharma. Jext® is expected to be the ...
Of this group, over the last three years, approximately 20 million people have been diagnosed and treated for severe Type I allergic reactions that may lead to anaphylaxis, but (in 2023, for example) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback